Group structure
11 companies in 8 countries
Loading your pageโฆ
Loading your pageโฆ
11 companies in 8 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1โ25 of 28
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| CATAPRESANSoluzione iniettabile | Clonidine | Italy | Authorised | |
| CATAPRESAN 0,150 mg COMPRIMIDOS0,150 mg ยท Comprimido | Clonidine | Spain | Marketed | 1972 |
| Catapresan, oplossing voor injectie 0,150 mg/mlOplossing voor injectie | Clonidine | Netherlands | Authorised | 1971 |
| FLEBOSTASIN RETARD 50 mg CรPSULAS DURAS DE LIBERACIรN PROLONGADA50 mg ยท Cรกpsula dura de liberaciรณn prolongada | Escina | Spain | Marketed | 1996 |
| MYOTONACHOL10mg | 25mg | 5mg ยท Tablet | Bethanechol | United States | Not marketed | 1975 |
| PASKALIUM1GM ยท Tablet | Sodium aminosalicylate | United States | Not marketed | 1955 |
| PASKALIUM500mg ยท Capsule | Sodium aminosalicylate | United States | Not marketed | 1955 |
| PERSANTINCompressa rivestita con film | Dipyridamole | Italy | Authorised | |
| PERSANTIN 100 mg COMPRIMIDOS RECUBIERTOS100 mg ยท Comprimido recubierto | Dipyridamole | Spain | Marketed | 1986 |
| Persantin 75 mg obloลพene tableteobloลพena tableta | Dipyridamole | Croatia | Marketed | 2020 |
| Persantin, injectievloeistof 5 mg/mlOplossing voor injectie | Dipyridamole | Netherlands | Authorised | 1988 |
| PERSANTINE5 mg / ml ยท Solution | Dipyridamole | Canada | Marketed | 1986 |
| PLENDIL10 mg ยท Tablet (Extended-Release) | Felodipine | Canada | Marketed | 1992 |
| PLENDIL5 mg ยท Tablet (Extended-Release) | Felodipine | Canada | Marketed | 1992 |
| PLENDILCompressa a rilascio prolungato | Felodipine | Italy | Authorised | |
| PLENDIL2.5 mg ยท Tablet (Extended-Release) | Felodipine | Canada | Marketed | 1994 |
| Plendil 2,5, tabletten met verlengde afgifte 2,5 mgTablet met verlengde afgifte | Felodipine | Netherlands | Authorised | 1992 |
| PLENDIL 5 mg COMPRIMIDOS DE LIBERACION PROLONGADA5 mg ยท Comprimido de liberaciรณn prolongada | Felodipine | Spain | Marketed | 1993 |
| PREVEXCompressa a rilascio prolungato | Felodipine | Italy | Authorised | |
| RENOQUID250mg ยท Tablet | Sulfacytine | United States | Not marketed | 1975 |
| BICHLORACETIC ACID 100%100 % / kit ยท Liquid | Dichloracetic acid | Canada | Cancelled | 1989 |
| DIODOQUIN TAB 210MG210 mg ยท Tablet | Diiodohydroxyquin | Canada | Cancelled | 1992 |
| DIODOQUIN TAB 650MG650 mg ยท Tablet | Diiodohydroxyquin | Canada | Cancelled | 1992 |
| MYOTONACHOL TABLETS 10MG10 mg ยท Tablet | Bethanechol | Canada | Cancelled | 1993 |
| MYOTONACHOL TABLETS 25MG25 mg ยท Tablet | Bethanechol | Canada | Cancelled | 1993 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 12 | 4 | 8 | CompaniesAll medicines |
| Spain | 4 | 4 | 0 | CompaniesAll medicines |
| Italy | 4 | 4 | 0 | CompaniesAll medicines |
| United States | 4 | 4 | 0 | CompaniesAll medicines |
| Netherlands | 3 | 3 | 0 | CompaniesAll medicines |
| Croatia | 1 | 1 | 0 | CompaniesAll medicines |
Also in the registers of France, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Fuente de la informaciรณn: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Report an error or request removalCorrections from the company itself are welcome.
Well-known pharmaceutical groups, each with all its companies.